Biktarvy generic name is called Taffic, a combination of three antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide.
It is a prescription medication used to treat HIV-1 infection.
Biktarvy is generally well-tolerated and effective at suppressing the HIV-1 virus and improving the overall health and quality of life of people living with HIV-1.
Biktarvy is a brand-name medication, and it is protected by patents that prevent other companies from producing and selling generic versions of the drug.
However, once the patents expire, other companies may be able to produce and sell generic versions of the medication.
Generic medications are copies of brand-name medications that are produced and sold at a lower cost.
In India, Biktarvy (Taffic) is available as a generic medication and is the source of HIV treatment for many Americans, Canadians and Mexicans.
For decades India has been a major producer of generic drugs, and it is likely that generic versions of Biktarvy will become more affordable once the patents expire.
This could make the medication more affordable at $10/month for people in the US & Canada and other countries who may not have the financial resources to pay for the brand-name version.
Biktarvy generic name (Taffic) – Efficacy
The efficacy of generic medications, including generic versions of Biktarvy, has been extensively studied and reviewed.
According to the New England Journal of Medicine, generic medications are generally safe and effective and are equivalent to their brand-name counterparts in terms of quality, safety, and effectiveness.
In conclusion, Biktarvy is a prescription medication used to treat HIV-1 infection.
It is a combination of three antiviral drugs and is generally well-tolerated and effective at suppressing the HIV-1 virus and improving the overall health and quality of life of people living with HIV-1.
Generic versions of Biktarvy are readily available now and will be more so in the future, and these medications are generally considered to be safe and effective.